These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10583442)

  • 1. The growth and the control of human immunodeficiency virus in the lung: implications for highly active antiretroviral therapy.
    White NC; Agostini C; Israel-Biet D; Semenzato G; Clarke JR
    Eur J Clin Invest; 1999 Nov; 29(11):964-72. PubMed ID: 10583442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced in vivo human immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia.
    Koziel H; Kim S; Reardon C; Li X; Garland R; Pinkston P; Kornfeld H
    Am J Respir Crit Care Med; 1999 Dec; 160(6):2048-55. PubMed ID: 10588627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
    J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HIV replication and pulmonary opportunistic infections].
    Israël-Biet D; Cadranel J
    Rev Mal Respir; 1998 Jun; 15(3):247-54. PubMed ID: 9677632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary function in human immunodeficiency virus infection. A prospective 18-month study of serial lung function in 474 patients.
    Mitchell DM; Fleming J; Pinching AJ; Harris JR; Moss FM; Veale D; Shaw RJ
    Am Rev Respir Dis; 1992 Sep; 146(3):745-51. PubMed ID: 1519857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and risk of pulmonary disease.
    Rosen MJ
    Semin Respir Infect; 1999 Dec; 14(4):301-8. PubMed ID: 10638509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pneumocystis carinii pneumonia in AIDS. New concepts for an old problem].
    Bottaro E
    Medicina (B Aires); 1999; 59(2):187-94. PubMed ID: 10413901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunistic infections shortly after beginning highly active antiretroviral therapy.
    Rodríguez-Rosado R; Soriano V; Dona C; González-Lahoz J
    Antivir Ther; 1998; 3(4):229-31. PubMed ID: 10682143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997.
    San-Andrés FJ; Rubio R; Castilla J; Pulido F; Palao G; de Pedro I; Costa JR; del Palacio A
    Clin Infect Dis; 2003 May; 36(9):1177-85. PubMed ID: 12715314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus and respiratory infection.
    Ashley EA; Johnson MA; Lipman MC
    Curr Opin Pulm Med; 2000 May; 6(3):240-5. PubMed ID: 10782710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current clinical aspects of HIV/AIDS].
    Zeller V; Caumes E; Bossi P; Bricaire F; Katlama C
    Presse Med; 2002 Jan; 31(2):74-9. PubMed ID: 11850990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of acquired immunodeficiency syndrome-related pulmonary Kaposi's sarcoma after highly active antiretroviral therapy.
    Aboulafia DM
    Mayo Clin Proc; 1998 May; 73(5):439-43. PubMed ID: 9581584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunistic infections and other AIDS-defining illnesses in Poland in 2000-2002.
    Podlasin RB; Wiercinska-Drapalo A; Olczak A; Beniowski M; Smiatacz T; Malolepsza E; Juszczyk J; Leszczyszyn-Pynka M; Mach T; Mian M; Knysz B; Horban A
    Infection; 2006 Aug; 34(4):196-200. PubMed ID: 16896577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report on the Fifth Conference on Retroviruses and Opportunistic Infections.
    Soloway B
    AIDS Clin Care; 1998 Apr; 10(4):27-9. PubMed ID: 11365150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and spectrum of AIDS-defining illnesses among persons treated with antiretroviral drugs.
    Michaels SH; Clark R; Kissinger P
    Clin Infect Dis; 1999 Aug; 29(2):468-9. PubMed ID: 10476778
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of lung infections associated with human immunodeficiency virus infection.
    Hopewell PC
    Thorax; 1989 Dec; 44(12):1038-44. PubMed ID: 2575801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series.
    Báez-Saldaña R; Villafuerte-García A; Cruz-Hervert P; Delgado-Sánchez G; Ferreyra-Reyes L; Ferreira-Guerrero E; Mongua-Rodríguez N; Montero-Campos R; Melchor-Romero A; García-García L
    PLoS One; 2015; 10(9):e0138115. PubMed ID: 26379281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM; Araneta MR; Deville JG; Spector SA
    Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.